Medbox Begins Operations in Oregon, New York, Illinois and Nevada Company strengthens position as a leader in the legal medical marijuana industry
HOLLYWOOD, Calif., July 22, 2013 /PRNewswire/ -- Medbox, Inc. (OTC Markets: MDBX) (www.medboxinc.com), a leader in providing consulting services and patented inventory control, compliance, and dispensing systems to the medical and retail industries, announced that they will begin providing their consulting services to interested parties in the states of Oregon, New York, Illinois and Nevada.
Just weeks ago, The Oregon House passed a bill legalizing medical marijuana retail establishments, moving the industry squarely into the mainstream, and handing medical marijuana advocates a major victory. House Bill 3460, creates a registry of businesses that sell medical marijuana. Patients have long sought retail access to medical cannabis, arguing the state's current rules that allow patients to grow their own marijuana are unrealistic.
A recent investigative report by The Oregonian, showed that the lack of state regulation of medical marijuana has allowed widespread diversion to the black market.
"We are pleased with the passage of this bill," stated Dr. Bruce Bedrick, CEO of Medbox, Inc. "This legislation aims to legitimize the industry, and take marijuana off the streets and into properly run and licensed dispensaries," he added. "We are strong proponents of any measures that help the medical marijuana industry conform to acknowledged standards and practices seen in the pharmacy industry, which will in turn benefit both patients and dispensary operators."
In June of this year, the New York State Assembly overwhelmingly passed a Medical Marijuana Bill, which now heads to the State Senate.
Both the Illinois and Nevada legislatures have recently approved a measure approving a limited number of medical marijuana dispensaries in their states. The company plans on aggressively targeting as many licenses as possible for its consulting clients in those states. Medbox points out that out of 97 total dispensary licenses available in a prior target market, Arizona, a total of 20 such licenses were awarded to Medbox consulting clients.
"We are in the process of establishing offices in these new target markets and will be drawing from our amazing success in Arizona to help us achieve success for our clients in obtaining as many licenses as possible in these new markets," stated Vincent Mehdizadeh, Chief Operations Officer of Medbox, Inc. "Clients demand results and since we consider ourselves the biggest and brightest star in this newly minted industry, we feel obligated to perform and humbled by the faith our clients put in us. Submitting an application for a dispensary license in these states is no small task and Medbox will always rise to the occasion with the best real estate, legal, technology, and consulting support available."
About Medbox, Inc:
Medbox is a leader in the development, sales and service of automated, biometrically controlled dispensing and storage systems for medicine and merchandise. Medbox has offices throughout the world, including New York, Arizona, Connecticut, Massachusetts, Tokyo, London and Toronto, and has their corporate headquarters in Los Angeles.
Medbox provides their patented systems, software and consulting services to pharmacies, dispensaries, urgent care centers, drug rehab clinics, hospitals, prison systems, hospice facilities, and medical groups worldwide.
Medbox, Inc. is a publicly traded company, and is quoted on the OTC Markets, ticker symbol MDBX.
For more information on Medbox, please contact the Medbox Investor Relations Department at (800) 762-1452 or go online to www.medboxinc.com.
Forward-Looking Statements: The statements in this press release constitute forward-looking statements within the meaning of federal securities laws. Such statements are based on our current beliefs and expectations and are inherently subject to significant business, economic and competitive uncertainties and contingencies, many of which are beyond our control. In addition, such forward-looking statements are subject to assumptions with respect to future business strategies and decisions that are subject to change. Potential risks and uncertainties include, but are not limited to, technical advances in the industry, political conditions and economic conditions in the states considering such legislation. We do not take any obligation to update any forward-looking statement to reflect events or developments after a forward-looking statement was made.
SOURCE Medbox, Inc.